Found: 80
Select item for more details and to access through your institution.
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single center prospective evaluation and desensitization strategies employed.
- Published in:
- Blood Transfusion (17232007), 2024, v. 22, n. 5, p. 157, doi. 10.2450/BloodTransfus.464
- By:
- Publication type:
- Article
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.
- Published in:
- Blood Transfusion (17232007), 2024, v. 22, n. 2, p. 157, doi. 10.2450/BloodTransfus.464
- By:
- Publication type:
- Article
A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00900-7
- By:
- Publication type:
- Article
Utility of procalcitonin and C-reactive protein as predictors of Gram-negative bacteremia in febrile hematological outpatients.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 5, p. 4303, doi. 10.1007/s00520-021-06782-w
- By:
- Publication type:
- Article
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1407, doi. 10.21873/invivo.11921
- By:
- Publication type:
- Article
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1338417
- By:
- Publication type:
- Article
Editorial: HBV and lymphoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1236816
- By:
- Publication type:
- Article
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1171031
- By:
- Publication type:
- Article
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1212638
- By:
- Publication type:
- Article
Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: An Italian Monocentric Experience.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.047
- By:
- Publication type:
- Article
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
- Published in:
- La Radiologia Medica, 2023, v. 128, n. 5, p. 556, doi. 10.1007/s11547-023-01622-9
- By:
- Publication type:
- Article
p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.
- Published in:
- Journal of Pathology, 2001, v. 195, n. 3, p. 361, doi. 10.1002/path.945
- By:
- Publication type:
- Article
Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications.
- Published in:
- Journal of Pathology, 1999, v. 188, n. 4, p. 400, doi. 10.1002/(SICI)1096-9896(199908)188:4<400::AID-PATH379>3.0.CO;2-#
- By:
- Publication type:
- Article
Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
- Published in:
- Journal of Pathology, 1997, v. 183, n. 3, p. 281, doi. 10.1002/(SICI)1096-9896(199711)183:3<281::AID-PATH1134>3.0.CO;2-Z
- By:
- Publication type:
- Article
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. e28, doi. 10.1111/bjh.18224
- By:
- Publication type:
- Article
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trial.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. 1184, doi. 10.1111/bjh.17971
- By:
- Publication type:
- Article
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 78, doi. 10.1111/bjh.17440
- By:
- Publication type:
- Article
Effect of low or high doses of low‐molecular‐weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID‐19.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 4, p. e214, doi. 10.1111/bjh.17003
- By:
- Publication type:
- Article
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. e217, doi. 10.1111/bjh.16114
- By:
- Publication type:
- Article
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18- FDG PET/ CT quantitative parameters in the International Extranodal Lymphoma Study Group ( IELSG) 26 study.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 588, doi. 10.1111/bjh.14728
- By:
- Publication type:
- Article
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 12, p. 3457, doi. 10.1007/s00277-023-05412-1
- By:
- Publication type:
- Article
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2963, doi. 10.1007/s00277-023-05329-9
- By:
- Publication type:
- Article
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 769, doi. 10.1007/s00277-023-05129-1
- By:
- Publication type:
- Article
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2773, doi. 10.1007/s00277-020-04096-1
- By:
- Publication type:
- Article
Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 10, p. 2405, doi. 10.1007/s00277-020-04217-w
- By:
- Publication type:
- Article
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 273, doi. 10.3390/jcm13010273
- By:
- Publication type:
- Article
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 11, p. 3777, doi. 10.3390/jcm12113777
- By:
- Publication type:
- Article
Lymphadenopathies before and during the Pandemic COVID-19: Increasing Incidence of Metastases from Solid Tumors.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 6979, doi. 10.3390/jcm11236979
- By:
- Publication type:
- Article
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia.
- Published in:
- Cancers, 2024, v. 16, n. 18, p. 3214, doi. 10.3390/cancers16183214
- By:
- Publication type:
- Article
Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2864, doi. 10.3390/cancers16162864
- By:
- Publication type:
- Article
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2411, doi. 10.3390/cancers15092411
- By:
- Publication type:
- Article
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1742, doi. 10.3390/cancers14071742
- By:
- Publication type:
- Article
High Basal Maximal Standardized Uptake Value (SUV max) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2876, doi. 10.3390/cancers13122876
- By:
- Publication type:
- Article
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 938, doi. 10.1111/ejh.14188
- By:
- Publication type:
- Article
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 4, p. 654, doi. 10.1111/ejh.14155
- By:
- Publication type:
- Article
One‐month qRT‐PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 6, p. 970, doi. 10.1111/ejh.14085
- By:
- Publication type:
- Article
Langerhans' cell histiocytosis in adults.
- Published in:
- Cancer (0008543X), 1997, v. 80, n. 9, p. 1786, doi. 10.1002/(SICI)1097-0142(19971101)80:9<1786::AID-CNCR13>3.0.CO;2-1
- By:
- Publication type:
- Article
Rituximab Combined With MACOP-B or VACOP-B and Radiation Therapy in Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 5, p. 381, doi. 10.3816/CLM.2009.n.074
- By:
- Publication type:
- Article
RECOGNIZING NON-FLOUNDERING LOGIC PROGRAMS AND GOALS.
- Published in:
- International Journal of Foundations of Computer Science, 1990, v. 1, n. 2, p. 151, doi. 10.1142/S0129054190000126
- By:
- Publication type:
- Article
Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 6, p. 554, doi. 10.1111/ejh.12768
- By:
- Publication type:
- Article
Logic-based specification languages for intelligent software agents.
- Published in:
- Theory & Practice of Logic Programming, 2004, v. 4, n. 4, p. 429, doi. 10.1017/S1471068404002029
- By:
- Publication type:
- Article
Model checking linear logic specifications.
- Published in:
- Theory & Practice of Logic Programming, 2004, v. 4, n. 5/6, p. 573, doi. 10.1017/S1471068404002066
- By:
- Publication type:
- Article
An effective fixpoint semantics for linear logic programs.
- Published in:
- Theory & Practice of Logic Programming, 2002, v. 2, n. 1, p. 85, doi. 10.1017/S1471068402001254
- By:
- Publication type:
- Article
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e286, doi. 10.1016/j.clml.2023.06.001
- By:
- Publication type:
- Article
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 420, doi. 10.1016/j.clml.2023.03.004
- By:
- Publication type:
- Article
Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e804, doi. 10.1016/j.clml.2022.04.010
- By:
- Publication type:
- Article
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article